Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
56 hedge funds and large institutions have $59M invested in Marrone Bio Innovations, Inc. in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
46% more capital invested
Capital invested by funds: $40.5M → $59M (+$18.5M)
31% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 16
6% more funds holding
Funds holding: 53 → 56 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$397K |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$357K |
| 3 |
BlackRock
New York
|
+$258K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$168K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$131K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$328K |
| 2 |
IAM
ICM Asset Management
Spokane,
Washington
|
-$214K |
| 3 |
State Street
Boston,
Massachusetts
|
-$185K |
| 4 |
Primecap Management
Pasadena,
California
|
-$55.8K |
| 5 |
JP Morgan Chase
New York
|
-$27.4K |
MBII Hedge Fund Activity: Q2 2020 in Review
56 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2020, worth a combined $59M — up 46% from $40.5M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MBII positions and 3 closed out — a net gain of 3 holders — while 21 added to existing stakes and 16 trimmed.
The largest buyer was Ardsley Advisory Partners, adding an estimated $397K. The largest seller was Essex Investment Management, exiting entirely with an estimated $328K sold.
- 56 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2020, up from 53 in Q1 2020.
- Funds reported $59M of Marrone Bio Innovations, Inc. stock for Q2 2020, up 46% quarter-over-quarter.
- 6 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2020 and 3 closed out, a net change of +3 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q2 2020 was Ardsley Advisory Partners, an estimated $397K added.
- The largest Marrone Bio Innovations, Inc. seller in Q2 2020 was Essex Investment Management, an estimated $328K sold.
Based on aggregated 13F filings for Q2 2020.